BriaCell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCTX and other ETFs, options, and stocks.About BCTX
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer.
CEOWilliam V. Williams
CEOWilliam V. Williams
Employees17
Employees17
HeadquartersWest Vancouver, British Columbia
HeadquartersWest Vancouver, British Columbia
Founded2006
Founded2006
Employees17
Employees17
BCTX Key Statistics
Market cap21.56M
Market cap21.56M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume46.26K
Average volume46.26K
High today$11.53
High today$11.53
Low today$9.94
Low today$9.94
Open price$9.94
Open price$9.94
Volume74.24K
Volume74.24K
52 Week high$190.50
52 Week high$190.50
52 Week low$6.00
52 Week low$6.00
Stock Snapshot
The current BriaCell Therapeutics(BCTX) stock price is $11.53, with a market capitalization of 21.56M. The stock trades at a price-to-earnings (P/E) ratio of -0.15.
On 2025-11-08, BriaCell Therapeutics(BCTX) stock traded between a low of $9.94 and a high of $11.53. Shares are currently priced at $11.53, which is +16.0% above the low and -0.0% below the high.
BriaCell Therapeutics(BCTX) shares are trading with a volume of 74.24K, against a daily average of 46.26K.
During the past year, BriaCell Therapeutics(BCTX) stock moved between $6.00 at its lowest and $190.50 at its peak.
During the past year, BriaCell Therapeutics(BCTX) stock moved between $6.00 at its lowest and $190.50 at its peak.
People also own
Based on the portfolios of people who own BCTX. This list is generated using Robinhood data, and it’s not a recommendation.